Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants-Reference-Cited by-同舟云学术

Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants

Author:

Jiang Haihai¹^ORCID,Zhou Yanru²,Zou Xiaofang³⁴,Hu Xiaohui¹,Wang Jie³,Zeng Pei³,Li Wenwen³,Zeng Xiangyi³,Zhang Jin¹,Li Jian²

Affiliation:

1. School of Basic Medical Sciences, Nanchang University, Nanchang 330031, China

2. College of Pharmaceutical Sciences, Gannan Medical University, Ganzhou 341000, China

3. Shenzhen Crystalo Biopharmaceutical Co., Ltd., Shenzhen 518118, China

4. Jiangxi Jmerry Biopharmaceutical Co., Ltd., Ganzhou 341000, China

Funder

Key Research and Development Program of Jiangxi Province

Science Fund for Distinguished Young Scholars of Jiangxi Province

National Natural Science Foundation of China

Natural Science Foundation of Jiangxi Province

Gannan Medical University

Chinese Academy of Sciences

Jiangxi Double Thousand Plan

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

Reference41 articles.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献